194 related articles for article (PubMed ID: 17466399)
1. Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screening.
Sanchez BA; Varotti FP; Rodrigues FG; Carvalho LH
J Microbiol Methods; 2007 Jun; 69(3):518-22. PubMed ID: 17466399
[TBL] [Abstract][Full Text] [Related]
2. A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity.
Corbett Y; Herrera L; Gonzalez J; Cubilla L; Capson TL; Coley PD; Kursar TA; Romero LI; Ortega-Barria E
Am J Trop Med Hyg; 2004 Feb; 70(2):119-24. PubMed ID: 14993620
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
Bacon DJ; Latour C; Lucas C; Colina O; Ringwald P; Picot S
Antimicrob Agents Chemother; 2007 Apr; 51(4):1172-8. PubMed ID: 17220424
[TBL] [Abstract][Full Text] [Related]
4. Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin.
Kuhn Y; Rohrbach P; Lanzer M
Cell Microbiol; 2007 Apr; 9(4):1004-13. PubMed ID: 17381432
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents.
Sanchez BA; Mota MM; Sultan AA; Carvalho LH
Int J Parasitol; 2004 Mar; 34(4):485-90. PubMed ID: 15013738
[TBL] [Abstract][Full Text] [Related]
6. Screening and evaluation of inhibitors of Plasmodium falciparum merozoite egress and invasion using cytometry.
Bouillon A; Gorgette O; Mercereau-Puijalon O; Barale JC
Methods Mol Biol; 2013; 923():523-34. PubMed ID: 22990802
[TBL] [Abstract][Full Text] [Related]
7. Effect of antimalarial drugs on Plasmodium falciparum gametocytes.
Peatey CL; Skinner-Adams TS; Dixon MW; McCarthy JS; Gardiner DL; Trenholme KR
J Infect Dis; 2009 Nov; 200(10):1518-21. PubMed ID: 19848586
[TBL] [Abstract][Full Text] [Related]
8. Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.
Rason MA; Randriantsoa T; Andrianantenaina H; Ratsimbasoa A; Menard D
Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):346-51. PubMed ID: 18321546
[TBL] [Abstract][Full Text] [Related]
9. Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives.
Noedl H; Wernsdorfer WH; Kollaritsch H; Looareesuwan S; Miller RS; Wongsrichanalai C
Wien Klin Wochenschr; 2003; 115 Suppl 3():23-7. PubMed ID: 15508776
[TBL] [Abstract][Full Text] [Related]
10. [Detection of antimalarial activity for new compounds by isotopic microtest].
Chen ZG; Moreno A; Benito A; Moreno M; Berzosa PJ; de Lucio A; Moyano E
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Feb; 27(1):83-6. PubMed ID: 19459510
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum: development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer.
Izumiyama S; Omura M; Takasaki T; Ohmae H; Asahi H
Exp Parasitol; 2009 Feb; 121(2):144-50. PubMed ID: 19017530
[TBL] [Abstract][Full Text] [Related]
12. Cyquant cell proliferation assay as a fluorescence-based method for in vitro screening of antimalarial activity.
Sriwilaijaroen N; Kelly JX; Riscoe M; Wilairat P
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):840-4. PubMed ID: 15916078
[TBL] [Abstract][Full Text] [Related]
13. An in vitro assay system for the identification of potential antimalarial drugs.
Geary TG; Divo AA; Jensen JB
J Parasitol; 1983 Jun; 69(3):577-83. PubMed ID: 6355423
[TBL] [Abstract][Full Text] [Related]
14. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.
Johnson JD; Dennull RA; Gerena L; Lopez-Sanchez M; Roncal NE; Waters NC
Antimicrob Agents Chemother; 2007 Jun; 51(6):1926-33. PubMed ID: 17371812
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum.
Basco LK
Am J Trop Med Hyg; 2004 May; 70(5):474-80. PubMed ID: 15155978
[TBL] [Abstract][Full Text] [Related]
16. A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
Garavito G; Monje MC; Maurel S; Valentin A; Nepveu F; Deharo E
Exp Parasitol; 2007 Jul; 116(3):311-3. PubMed ID: 17336296
[TBL] [Abstract][Full Text] [Related]
17. A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum.
Dixon MW; Peatey CL; Gardiner DL; Trenholme KR
Mol Biochem Parasitol; 2009 Feb; 163(2):123-6. PubMed ID: 19027798
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antimalarial and fluoroquinolone combinations against Plasmodium falciparum in vitro.
Soares RP; Krettli AU; de Souza MV; Vasconcelos TR; Boechat N
Int J Antimicrob Agents; 2006 Sep; 28(3):271-2. PubMed ID: 16904872
[No Abstract] [Full Text] [Related]
19. An efficient fluorimetric method to measure the viability of intraerythrocytic Plasmodium falciparum.
Evers A; Heppner S; Leippe M; Gelhaus C
Biol Chem; 2008 Dec; 389(12):1523-5. PubMed ID: 18844447
[TBL] [Abstract][Full Text] [Related]
20. One-step Plasmodium falciparum cultivation--application to in-vitro drug testing.
Druilhe P; Mazier D; Brandicourt O; Gentilini M
Tropenmed Parasitol; 1983 Dec; 34(4):233-4. PubMed ID: 6364513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
